This article has been updated from a version posted Oct. 15 to include additional information from the company.
Xagenic, a Toronto-based company developing a menu of chip-based tests, recently received over C$1 million ($996,000) in financing from Canadian investors.
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
